|
|
Study on the Gene Distribution and Relationship of Human Leukocyte Antigen (HLA) in Patients with Severe Skin Allergy Reaction Induced by Anti-Epileptic Drugs |
FANG Deng-fu, ZHANG Bo, CHEN Xiao-rong |
Suining Central Hospital, Suining, Sichuan 629000 |
|
|
Abstract 【Objective】To analyze the gene distribution of human leukocyte antigen (HLA) in patients with severe skin allergy reaction induced by anti-epileptic drugs. 【Methods】 Sixty patients with skin allergy reaction induced by anti-epileptic drugs who were treated between March 2013and March 2016 were selected as study subjects, including 35 patients with mild skin allergy reaction(mild group) and 25 patients with severe skin allergy reaction (severe group). At the same time, another 40 normal healthy persons were selected as control group. The distribution of HLA-B* 1502 in the three groups was determined by PCR-SSP method. The frequency of HLA-B* 1502, HLA-A* 1101、HLA-A* 3101 was compared between the three groups and the relationship between skin allergy reaction induced by anti-epileptic drugs and HLA genotype was analyzed. 【Results】The frequency of HLA-B* 1502 gene in the severe group (56.00%) was significantly higher than that in the mild group and the control group (11.43%, 7.50%) (P<0.05); Skin allergy reaction induced by anti-epileptic drugs was related to HLA-B * 1502, HLA-A * 1101, HLA-A * 3101 and HLA-B * 1511 (P<0.05), while mild skin allergy reaction had no significant correlation with genes mentioned above (P>0.05) (except for HLA-A * 3101). The severe skin allergy reactions in 25 cases were caused by the aromatic anti-epileptic drugs. 【Conclusion】 The main HLA genes of severe skin allergy reaction induced by anti-epileptic drugs are HLA-B * 1502 and HLA-B* 1511. Severe skin allergy reaction induced by anti-epileptic drugs is significantly related to positive HLA-B * 1502 and other genes. The detection of HLA-B *1502 and other genotypes is suggested before anti-epileptic drug therapy. If it is positive, aromatic antiepileptic drug treatment ought to be avoided.
|
|
|
|
|
|
[1] 王广新,杨作成.儿童难治性癫痫的临床特点分析[J].湖南师范大学学报(医学版),2010,7(4):16-18. [2] 赵久晗,商秀丽.大剂量苯巴比妥口服治疗儿童期难治性癫痫17例临床观察[J].医学临床研究,2012,29(3):466-468. [3] 吴培培.抗癫痫药物等引发药疹与人类白细胞抗原基因的相关性研究[J].中国药理学通报,2013,29(1):113-117. [4] 张建斌,杜晓萍,刘玉玺,等.抗癫痫药物致皮肤超敏反应12例临床分析[J].中国药物与临床,2015,15(1):86-88. [5] 何汝茜,范甜甜,包怡心,等.抗癫痫药物致皮肤型药物不良反应与HLA基因关系的研究进展[J].药物流行病学杂志,2014,23(3):189-194. [6] 王湘庆.抗癫痫药物的皮肤过敏反应机制和遗传因素研究进展[J].军医进修学院学报,2010,31(10):1039-1041. [7] 王旭.HLA基因与芳香族抗癫痫药物诱发皮肤不良反应相关性研究进展[J].中风与神经疾病杂志,2015,32(4):373-375. [8] 王剑虹,吴洵昳,虞培敏,等.抗癫痫药物间交叉过敏患者二例临床特点及其人类白细胞抗原-B*1502基因分析[J].中华神经科杂志,2011,44(10):674-676. [9] 吴欣桐. HLA-A-B-DRB1单倍型与抗癫痫药物所致皮肤不良反应间的关系[J].西部医学,2015,27(6):816-821. [10] McCormack M,Alfirevic A,Bourgeois S,et al.HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans[J].NEJM,2011,364(12):1134-1143. [11] Takeshi O.Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population[J].Hum Mol Genet,2011,20(5):1034-1041.
|
|
|
|